DE69825746D1 - Verfahren und zwischenprodukte zur trennung von piperidylacetamid-stereoisomeren - Google Patents

Verfahren und zwischenprodukte zur trennung von piperidylacetamid-stereoisomeren

Info

Publication number
DE69825746D1
DE69825746D1 DE69825746T DE69825746T DE69825746D1 DE 69825746 D1 DE69825746 D1 DE 69825746D1 DE 69825746 T DE69825746 T DE 69825746T DE 69825746 T DE69825746 T DE 69825746T DE 69825746 D1 DE69825746 D1 DE 69825746D1
Authority
DE
Germany
Prior art keywords
stereoisomers
separating
intermediate products
threo
piperidyl acetamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69825746T
Other languages
English (en)
Other versions
DE69825746T2 (de
Inventor
Vikram Khetani
Yalin Luo
Sowmianarayanan Ramaswamy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Celgene Corp
Original Assignee
Celgene Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celgene Corp filed Critical Celgene Corp
Application granted granted Critical
Publication of DE69825746D1 publication Critical patent/DE69825746D1/de
Publication of DE69825746T2 publication Critical patent/DE69825746T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
DE69825746T 1997-05-22 1998-05-18 Verfahren und Zwischenprodukte zur Trennung von Piperidylacetamid-Stereoisomeren Expired - Lifetime DE69825746T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/861,988 US5936091A (en) 1997-05-22 1997-05-22 Processes and intermediates for resolving piperidyl acetamide stereoisomers
US861988 1997-05-22
PCT/US1998/010131 WO1998052921A1 (en) 1997-05-22 1998-05-18 Processes and intermediates for resolving piperidyl acetamide stereoisomers

Publications (2)

Publication Number Publication Date
DE69825746D1 true DE69825746D1 (de) 2004-09-23
DE69825746T2 DE69825746T2 (de) 2005-08-18

Family

ID=25337317

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69825746T Expired - Lifetime DE69825746T2 (de) 1997-05-22 1998-05-18 Verfahren und Zwischenprodukte zur Trennung von Piperidylacetamid-Stereoisomeren

Country Status (13)

Country Link
US (1) US5936091A (de)
EP (2) EP1506961B1 (de)
JP (1) JP4439595B2 (de)
AT (2) ATE273952T1 (de)
AU (1) AU735353B2 (de)
CA (1) CA2291170C (de)
CY (1) CY1113023T1 (de)
DE (1) DE69825746T2 (de)
DK (2) DK1506961T3 (de)
ES (2) ES2226131T3 (de)
HK (1) HK1071895A1 (de)
PT (2) PT983238E (de)
WO (1) WO1998052921A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5837284A (en) * 1995-12-04 1998-11-17 Mehta; Atul M. Delivery of multiple doses of medications
US6486177B2 (en) * 1995-12-04 2002-11-26 Celgene Corporation Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate
US5922736A (en) * 1995-12-04 1999-07-13 Celegene Corporation Chronic, bolus administration of D-threo methylphenidate
US6962997B1 (en) * 1997-05-22 2005-11-08 Celgene Corporation Process and intermediates for resolving piperidyl acetamide steroisomers
US6127385A (en) * 1999-03-04 2000-10-03 Pharmaquest Limited Method of treating depression using l-threo-methylphenidate
US6395752B1 (en) * 1999-03-04 2002-05-28 Pharmaquest Limited Method of treating depression using 1-threo-methylphenidate
US20020187192A1 (en) * 2001-04-30 2002-12-12 Yatindra Joshi Pharmaceutical composition which reduces or eliminates drug abuse potential
US6638533B2 (en) 2002-01-03 2003-10-28 George Krsek Pulse dosage formulations of methylphenidate and method to prepare same
CH712083B1 (de) * 2003-02-05 2017-07-31 Siegfried Ag Verfahren zur Herstellung von d-threo-2-Phenyl-2-piperidin-2-yl-essigsäureestern.
US20050239830A1 (en) * 2004-04-26 2005-10-27 Vikram Khetani Methods of diminishing co-abuse potential
AU2005313887B2 (en) * 2004-12-09 2011-10-27 Celgene Corporation Treatment using D-threo methylphenidate
CN101786982A (zh) * 2010-03-30 2010-07-28 华东师范大学 一种合成2-吡啶基苯乙腈的方法
JP5886869B2 (ja) 2010-12-17 2016-03-16 ローズ テクノロジーズ メチルフェニデート塩酸塩の低温合成
US9233924B2 (en) 2014-03-11 2016-01-12 Ampac Fine Chemicals Llc Methods for preparing D-threo methylphenidate using diazomethane, and compositions thereof
EP3484850A4 (de) 2016-07-18 2019-12-11 Harman Finochem Limited Verbessertes verfahren zur herstellung von dexmethylphenidathydrochlorid
CN115322141B (zh) * 2022-09-01 2024-04-16 凯特立斯（深圳）科技有限公司 一种不对称氢化制备手性哌甲酯类化合物的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2507631A (en) * 1944-01-19 1950-05-16 Ciba Pharm Prod Inc Pyridine and piperidine compounds and process of making same
US2957880A (en) * 1953-12-23 1960-10-25 Ciba Pharm Prod Inc Process for the conversion of stereoisomers

Also Published As

Publication number Publication date
CY1113023T1 (el) 2016-04-13
EP1506961A2 (de) 2005-02-16
DE69825746T2 (de) 2005-08-18
DK0983238T3 (da) 2004-11-29
PT1506961E (pt) 2012-05-07
CA2291170C (en) 2008-09-16
DK1506961T3 (da) 2012-05-21
CA2291170A1 (en) 1998-11-26
AU7495598A (en) 1998-12-11
US5936091A (en) 1999-08-10
EP1506961B1 (de) 2012-02-22
EP0983238A4 (de) 2001-08-08
ATE546429T1 (de) 2012-03-15
WO1998052921A1 (en) 1998-11-26
JP4439595B2 (ja) 2010-03-24
HK1071895A1 (en) 2005-08-05
ES2381361T3 (es) 2012-05-25
EP1506961A3 (de) 2007-01-03
AU735353B2 (en) 2001-07-05
PT983238E (pt) 2004-10-29
EP0983238B1 (de) 2004-08-18
ATE273952T1 (de) 2004-09-15
ES2226131T3 (es) 2005-03-16
JP2002515066A (ja) 2002-05-21
EP0983238A1 (de) 2000-03-08

Similar Documents

Publication Publication Date Title
HK1071895A1 (en) Processes for resolving piperidyl acetamide stereoisomers
ATE145891T1 (de) Verfahren zur herstellung von alkoxyiminoacetamid-derivaten und ein zwischenproduckt dafür
ATE162529T1 (de) Verfahren zur herstellung von verbrückten, chiralen metallocenkatalysatoren des types bisindenyl
DE69527429T2 (de) Verfahren zur herstellung von wasserfreien und hydrat-formen von antihistaminischen piperinderivaten, polymerphe und pseudomorphe davon
DE69513458D1 (de) Verfahren zur Herstellung von hochmolekularen Milchsäure-Copolyestern
ATE277999T1 (de) Verfahren zur herstellung von amin- umsetzungsprodukt-teilchen
ATE201025T1 (de) Verfahren zur herstellung von cephalosporinen und zwischenprodukte in diesem verfahren
DE69611835T2 (de) Verfahren zur herstellung von 1-aryl-1-cyanocyclobutan-derivaten
ATE70064T1 (de) Verfahren zur herstellung von penemen.
ATE200276T1 (de) Verfahren zur herstellung von diacylimiden
ATE233267T1 (de) Verfahren zur herstellung von 3- vinylcephalosporinen
ATE125254T1 (de) Verfahren zur racematspaltung von 5-alkoxy- substituierten (+/-)-1,3- dimethyloxindolylethylaminen.
DE69502145D1 (de) Verbessertes Verfahren zur Herstellung von Iodoniumsalzen
ATE237583T1 (de) Verfahren zur herstellung von depsipeptiden und zwischenprodukten davon
DE69330130D1 (de) Verfahren zur herstellung von optisch aktiven 1,4-dihydropyridinen
ATE146785T1 (de) Verfahren zur herstellung von diltiazem
ATE154022T1 (de) Verfahren zur herstellung von epibatidin
ATE311382T1 (de) Verfahren zur herstellung von 2-carbamoyl- pyridinen
ATE299498T1 (de) Verfahren zur herstellung von imidazolderivaten
DE69016380D1 (de) Verfahren zur Herstellung von molluskiziden 2,4,5-Tribrompyrrol-3-Carbonitrilen.
DE69819315D1 (de) Verfahren zur herstellung von piperidincarbonsäureamiden
DE69606679D1 (de) Verfahren zur Herstellung von Aryl- und Vinylnitrilen
ATE215528T1 (de) Verfahren zur herstellung von alpha- aminosäureamide, alpha-aminosäuren und ihre derivaten
ATE133656T1 (de) Verfahren zur herstellung von 2-amino-5,6- dimethoxy tetralin
ATE191508T1 (de) Mikrobiologisches verfahren zur herstellung von 1-ungesättigten, 17-beta-carboxysubstituierten 3- oxo-4-azaandrostan-3-onen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition